KEYNOTE SPEAKER SPOTLIGHT: Advancing the Frontiers of Cellular Immunotherapy 

More Information on Dr. Rezvani 

Join us for a keynote presentation by Katy Rezvani, MD, PhD, FRCP, FRCPath, whose groundbreaking work in CAR NK cell therapies is redefining what’s possible in cancer treatment. With a focus on developing innovative natural killer (NK) cell–based therapies, Dr. Rezvani and her team are working to offer new treatment options for patients who have exhausted all standard therapies.

Her research demonstrates how engineering NK cells with chimeric antigen receptors (CARs) can overcome resistance, enhance efficacy, and broaden the reach of immunotherapy beyond current limitations. Seeing patients with no remaining treatment options achieve remission underscores both the urgency and promise of this work—and its potential to transform outcomes across multiple cancer types.

Don’t miss this opportunity to hear firsthand how next-generation CAR NK therapies are moving from bench to bedside and reshaping the future of oncology!

Symposium Registration 

ABSTRACTS AND AWARDS

Abstract Submissions are closed! 

Renowned experts of the ICHS Program Committee are preparing for a state-of-the-art scientific program that includes the most updated information about all aspects of infections and immunodeficiency. 

Abstracts from Early Career Level Scientists are highly encouraged and are eligible for the prestigious top abstracts awards to be presented during the Symposium program, May 14-17, 2026, in Houston, Texas, USA.

Dates:

Notifications of Abstract acceptance: January 12, 2026

Notifications for Top Abstract Awards: February 1, 2026

Contact ICHS at admin@ichs.org with any questions. 

JOIN US

Registration and More Information

Please join us for this dynamic ICHS educational event offering comprehensive scientific programming, insights into cutting-edge research, innovative care practices, and effective management strategies for immunocompromised hosts.

Attendees will have the opportunity to engage in cutting-edge discussions, interactive sessions, and networking opportunities with the experts and industry leaders. Our corporate partners will also showcase the latest developments in diagnostics and therapeutics, offering valuable insights into the future of patient care.

ICHS members received a reduced registration fee for educational events. New reduced $25 annual membership dues are now offered. For assistance with your membership, please contact us at admin@ichs.org.

As a member of ICHS, you will gain access to a wealth of resources, networking opportunities, and exclusive benefits tailored to support your professional growth.

Click here for more information on the symposium.

ICHS Membership: Click Here For More Information